tradingkey.logo

TherapeuticsMD Inc

TXMD
1.700USD
+0.030+1.80%
收盤 12/19, 16:00美東報價延遲15分鐘
19.68M總市值
64.96本益比TTM

TherapeuticsMD Inc

1.700
+0.030+1.80%

關於 TherapeuticsMD Inc 公司

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc簡介

公司代碼TXMD
公司名稱TherapeuticsMD Inc
上市日期Jan 31, 2001
CEOWalker (Marlan D)
員工數量1
證券類型Ordinary Share
年結日Jan 31
公司地址951 Yamato Road, Suite 220
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33431
電話15619611900
網址https://www.therapeuticsmd.com/
公司代碼TXMD
上市日期Jan 31, 2001
CEOWalker (Marlan D)

TherapeuticsMD Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
Non-U.S
642.00K
67.44%
United States
310.00K
32.56%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.26%
Tejara Capital Ltd.
2.97%
Adar1 Capital Management LLC
1.81%
其他
76.17%
持股股東
持股股東
佔比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.26%
Tejara Capital Ltd.
2.97%
Adar1 Capital Management LLC
1.81%
其他
76.17%
股東類型
持股股東
佔比
Hedge Fund
18.44%
Investment Advisor
7.63%
Individual Investor
1.55%
Investment Advisor/Hedge Fund
1.39%
Research Firm
1.13%
其他
69.86%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
82
3.26M
28.17%
-348.35K
2025Q2
88
5.28M
45.63%
+1.46M
2025Q1
93
3.58M
30.94%
-393.28K
2024Q4
95
3.73M
32.32%
-2.03M
2024Q3
99
3.59M
31.15%
-463.34K
2024Q2
121
3.62M
31.37%
-2.25M
2024Q1
209
3.66M
32.13%
-802.21K
2023Q4
230
4.54M
44.12%
-1.60M
2023Q3
274
4.44M
43.31%
-158.22K
2023Q2
299
4.48M
44.55%
-545.84K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Rubric Capital Management LP
1.19M
10.3%
-1.75M
-59.54%
Jun 30, 2025
Clearline Capital LP
635.22K
5.49%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
379.00K
3.27%
-2.94K
-0.77%
Jun 30, 2025
Tejara Capital Ltd.
344.25K
2.97%
-341.00
-0.10%
Jun 30, 2025
Adar1 Capital Management LLC
209.21K
1.81%
-60.95K
-22.56%
Jun 30, 2025
Morgan Stanley & Co. LLC
130.12K
1.12%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
116.13K
1%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
109.08K
0.94%
-2.42K
-2.17%
Jun 30, 2025
Walker (Marlan D)
73.64K
0.64%
+2.79K
+3.94%
Apr 18, 2025
Collins (Cooper C)
60.52K
0.52%
--
--
Apr 18, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
公告日期
類型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1

常見問題

TherapeuticsMD Inc的前五大股東是誰?

TherapeuticsMD Inc的前五大股東如下:
Rubric Capital Management LP
持有股份:1.19M
佔總股份比例:10.30%。
Clearline Capital LP
持有股份:635.22K
佔總股份比例:5.49%。
The Vanguard Group, Inc.
持有股份:379.00K
佔總股份比例:3.27%。
Tejara Capital Ltd.
持有股份:344.25K
佔總股份比例:2.97%。
Adar1 Capital Management LLC
持有股份:209.21K
佔總股份比例:1.81%。

TherapeuticsMD Inc的前三大股東類型是什麼?

TherapeuticsMD Inc 的前三大股東類型分別是:
Rubric Capital Management LP
Clearline Capital LP
The Vanguard Group, Inc.

有多少機構持有TherapeuticsMD Inc(TXMD)的股份?

截至2025Q3,共有82家機構持有TherapeuticsMD Inc的股份,合計持有的股份價值約為3.26M,占公司總股份的28.17% 。與2025Q2相比,機構持股有所增加,增幅為-17.46%。

哪個業務部門對TherapeuticsMD Inc的收入貢獻最大?

在FY2025Q2,--業務部門對TherapeuticsMD Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI